- Despite stricter Sebi norms, companies line up to buy back shares, UPL, Mastek, Claris Lifesciences in lineMarkets to see volatility amid F&O expiry, GDP dataMarket Capitalisation: Infosys, TCS, Reliance and six other companies add Rs 1,14,806 crHDFC Mutual Fund set to launch 'HDFC Debt Fund for Cancer Cure 2014'†
Shares of Claris Lifesciences gained more than 8% intraday after the drugmaker said that the equity shareholders of the company had approved the Rs 231 crore buyback.
"The equity shareholders of the company have approved the buy back of up to 92.50 lakh shares," the company said in an exchange filing on Friday. The buyback has been priced at Rs 250.
The scrip ended 0.69% higher at Rs 181.60 on Friday on the BSE.